Loading
TAMPA — Antibiotics developer Oragenics Inc. named Alan Joslyn the company's new top executive.
Effective June 6, Joslyn is Oragenics' president and CEO, a statement says. He is also a member of the company's board of directors.
Joslyn most recently served as a founding partner in Pennsylvania-based Lazarus Pharmaceuticals, the statement says. He has also worked as CEO and director of multiple privately held companies.
Oragenics Inc. is a developer of antibiotics against infectious disease and treatments for oral mucositis, the statement says. The business, founded in 1996, has established two worldwide collaborations with Intrexon Corporation Inc., a synthetic biology company.
Your free article limit has been reached this month.
Subscribe now for unlimited digital access to our award-winning business news.
Join thousands of executives who rely on us for insights spanning Tampa Bay to Naples.
